Sentinel lymph nodes in cutaneous melanoma

Clinics in Laboratory Medicine

Volumn 31, Issue 2, 2011, Pages 301-310

  Prieto, Victor G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Capsular nevus; Immunoperoxidase; Melanoma; Sentinel lymph node; Tumor burden

Indexed keywords

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH ANALYSIS; LYMPH NODE BIOPSY; LYMPHATIC SYSTEM EXAMINATION; MELANOMA; MELANOMA CELL; MICROSCOPY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENTINEL LYMPH NODE; SKIN CANCER;

HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; NEVUS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 79955542824     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2011.03.007     Document Type: Review

References (41)

1. Kaur C., Thomas R.J., Desai N., et al. The correlation of regression in primary melanoma with sentinel lymph node status. J Clin Pathol 2008, 61(3):297-300.
2. Prieto V.G. Use of frozen sections in the examination of sentinel lymph nodes in patients with melanoma. Semin Diagn Pathol 2008, 25(2):112-115.
3. Messina J.L., Glass L.F., Cruse C.W., et al. Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol 1999, 23(6):686-690.
4. Creager A.J., Shiver S.A., Shen P., et al. Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology. Cancer 2002, 94(11):3016-3022.
5. Gershenwald J.E., Colome M.I., Lee J.E., et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998, 16(6):2253-2260.
6. Clary B.M., Brady M.S., Lewis J.J., et al. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg 2001, 233(2):250-258.
7. Cochran A.J. Surgical pathology remains pivotal in the evaluation of 'sentinel' lymph nodes. Am J Surg Pathol 1999, 23(10):1169-1172.
8. Prieto V.G., Clark S.H. Processing of sentinel lymph nodes for detection of metastatic melanoma. Ann Diagn Pathol 2002, 6(4):257-264.
9. Gibbs J.F., Huang P.P., Zhang P.J., et al. Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes. Ann Surg Oncol 1999, 6(7):699-704.
10. Yu L.L., Flotte T.J., Tanabe K.K., et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 1999, 86(4):617-627.
11. Shidham V.B., Qi D.Y., Acker S., et al. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45. Am J Surg Pathol 2001, 25(8):1039-1046.
12. Abrahamsen H.N., Hamilton-Dutoit S.J., Larsen J., et al. Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision. Cancer 2004, 100(8):1683-1691.
13. Shidham V.B., Qi D., Rao R.N., et al. Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with 'MCW Melanoma Cocktail' - a mixture of monoclonal antibodies to MART-1, melan-A, and tyrosinase. BMC Cancer 2003, 3(1):15.
14. Prieto V.G., Shea C.R. Use of immunohistochemistry in melanocytic lesions. J Cutan Pathol 2008, 35(Suppl 2):1-10.
15. Trejo O., Reed J.A., Prieto V.G. Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56/N-CAM and GAP-43: evidence of early Schwann cell differentiation. J Cutan Pathol 2002, 29(7):397-406.
16. Carson K.F., Wen D.R., Li P.X., et al. Nodal nevi and cutaneous melanomas. Am J Surg Pathol 1996, 20(7):834-840.
17. Lohmann C.M., Iversen K., Jungbluth A.A., et al. Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma. Am J Surg Pathol 2002, 26(10):1351-1357.
18. Biddle D.A., Evans H.L., Kemp B.L., et al. Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma. Am J Surg Pathol 2003, 27(5):673-681.
19. Prieto V.G., Diwan A.D., Lazar A.F.J., et al. Histologic quantification of tumor size in sentinel lymph node metastases correlates with prognosis in patients with cutaneous malignant melanoma. Mod Pathol 2006, 19(Suppl1):87A.
20. Batistatou A., Cook M.G., Massi D. Histopathology report of cutaneous melanoma and sentinel lymph node in Europe: a web-based survey by the dermatopathology Working Group of the European Society of Pathology. Virchows Arch 2009, 454(5):505-511.
21. Cascinelli N., Belli F., Santinami M., et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000, 7(6):469-474.
22. Gershenwald J.E., Thompson W., Mansfield P.F., et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999, 17(3):976-983.
23. Rousseau D.L., Ross M.I., Johnson M.M., et al. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann Surg Oncol 2003, 10(5):569-574.
24. Topping A., Dewar D., Rose V., et al. Five years of sentinel node biopsy for melanoma: the St George's Melanoma Unit experience. Br J Plast Surg 2004, 57(2):97-104.
25. Frankel T.L., Griffith K.A., Lowe L., et al. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?. Ann Surg Oncol 2008, 15(9):2403-2411.
26. Page A.J., Carlson G.W., Delman K.A., et al. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma. Am Surg 2007, 73(7):674-678. [discussion: 678-9].
27. Debarbieux S., Duru G., Dalle S., et al. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Br J Dermatol 2007, 157(1):58-67.
28. Sabel M.S., Griffith K., Sondak V.K., et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg 2005, 201(1):37-47.
29. Gershenwald J.E., Andtbacka R.H., Prieto V.G., et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol 2008, 26(26):4296-4303.
30. Guggenheim M., Dummer R., Jung F.J., et al. The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma-a retrospective analysis of 392 cases. Br J Cancer 2008, 98(12):1922-1928.
31. Dewar D.J., Newell B., Green M.A., et al. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol 2004, 22(16):3345-3349.
32. Rossi C.R., De Salvo G.L., Bonandini E., et al. Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node. Ann Surg Oncol 2008, 15(4):1202-1210.
33. van Akkooi A.C., Bouwhuis M.G., de Wilt J.H., et al. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma. Br J Surg 2007, 94(10):1293-1299.
34. Wright B.E., Scheri R.P., Ye X., et al. Importance of sentinel lymph node biopsy in patients with thin melanoma. Arch Surg 2008, 143(9):892-899. [discussion: 899-900].
35. Guggenheim M.M., Hug U., Jung F.J., et al. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann Surg 2008, 247(4):687-693.
36. Satzger I., Völker B., Al Ghazal M., et al. Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients. Histopathology 2007, 50(6):764-772.
37. Romanini A., Manca G., Pellegrino D., et al. Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome. Ann Oncol 2005, 16(11):1832-1840.
38. Gradilone A., Ribuffo D., Silvestri I., et al. Detection of melanoma cells in sentinel lymph nodes by reverse transcriptase-polymerase chain reaction: prognostic significance. Ann Surg Oncol 2004, 11(11):983-987.
39. Mocellin S., Hoon D.S., Pilati P., et al. Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis. J Clin Oncol 2007, 25(12):1588-1595.
40. Scoggins C.R., Ross M.I., Reintgen D.S., et al. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol 2006, 24(18):2849-2857.
41. Hershko D.D., Robb B.W., Lowy A.M., et al. Sentinel lymph node biopsy in thin melanoma patients. J Surg Oncol 2006, 93(4):279-285.